Hansoh Pharmaceutical Group Company Limited
3692
Pozycja w akcjach
#901
Hansoh Pharmaceutical Group Company Limited, an investment holding company,... Hansoh Pharmaceutical Group Company Limited, an investment holding company, engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China. The company provides products for therapeutic areas, including anti-infection, central nervous system, oncology, and metabolic and other diseases, as well as autoimmune diseases. Its principal products include Ameile, Hansoh Xinfu, Pulaile, Zefei, Xintai, Xinmei, Gainuo, Tanneng, and Pulaitan; Hengmu, Mailingda, Hengsen, Oulanning, Ailanning, and Ameining; XINYUE; and Saint Luolai, Fulaimei, Ruibote, Fulaidi, Fulairui, Punuoan tablets, etc. It has licence agreements with GlaxoSmithKline Intellectual Property (No.4) Limited to develop, manufacture, and commercialize HS-20089 and HS-20093 for the treatment of patients with extensive-stage small-cell lung cancer (ES-SCLC) with disease progression on or after platinum-based chemotherapy; Biotheus Inc. to develop, produce, and commercialize bispecific antibody-drug conjugate product; and with Merck Sharp & Dohme LLC (MSD) to develop, manufacture, and commercialize HS-10535, an investigational pre-clinical oral small molecule glucagon-like peptide-1 (GLP-1) receptor agonist. The company was founded in 1995 and is headquartered in Shanghai, China. Hansoh Pharmaceutical Group Company Limited is a subsidiary of Stellar Infinity Company Ltd.
Cena akcji
$4.40
Kapitalizacja rynkowa
$26.66B
Zmiana (1 dzień)
8.32%
Zmiana (1 rok)
-6.19%
Kraj
CN
Handel Hansoh Pharmaceutical Group Company Limited (3692)
Kategoria
Healthcare
Historia stopy dywidendy dla Hansoh Pharmaceutical Group Company Limited (3692)
Stopa dywidendy (TTM) dla Hansoh Pharmaceutical Group Company Limited (symbol akcji: 3692) na dzień 2023-12-31 wynosi: 0.73%
Średnia stopa dywidendy z ostatnich 5 lat: 1.25%
Średnia stopa dywidendy z ostatnich 5 lat: 1.25%
Historia stopy dywidendy dla Hansoh Pharmaceutical Group Company Limited (3692) od 2016 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
| Rok | Stopa dywidendy | Zmień |
|---|---|---|
| 2026 (TTM) | 1.54% | -20.21% |
| 2024 | 1.93% | 164.38% |
| 2023 | 0.73% | -20.65% |
| 2022 | 0.92% | 119.05% |
| 2021 | 0.42% | -81.42% |
| 2020 | 2.26% | 91.53% |
| 2019 | 1.18% | 0.00% |
| 2018 | 0.00% | -100.00% |
| 2017 | 0.44% | -81.51% |
| 2016 | 2.38% | 0.00% |
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji
| Firma | Stopa dywidendy | Kraj |
|---|---|---|
| 0.00% |
DE
|
|
| 0.00% |
DE
|
|
| 0.00% |
JP
|
|
| 0.00% |
CH
|
|
| 0.91% |
IN
|
